Form 4 for CAI Caris Life Sciences, Inc.
Accepted 2026-02-27 00:00:00 ET · period of report 2026-02-26 · accession 0001239594-26-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-27 | 2026-02-26 | CAI | CASTLEMAN PETER M | Dir | A - Grant | $20.06 | +5,509 | 24.1K | +30% | +$110.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-26 | A | A | 5,509 | $20.06 | 24,138 | D | — | — |